Note, these are not mutually exclusive
Diabetes Care 39:12411249 Kazierad DJ, Bergman A, Tan B et al (2016) Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus
Loss of neuronal GSH has also been linked to microglial activation and complement-mediated neurodegeneration, further emphasizing the link between redox imbalance and immune dysregulation (Hashimoto et al., 2023)
Dosing regimens vary between short-acting and long-acting formulations
Scientists think its possible Many with PMOS, Zilbermint said, can also have insulin resistance, which means that while their body produces the hormone, it doesnt utilize it as well as other people
Language throughout this section is intentionally cautious